Q2 2026 saw improved profitability, with ROAA at 1.97% and ROAE at 14.5%. Net interest income rose 2.6% sequentially, and efficiency ratio improved to 56.2%. Loan and deposit growth remained solid, capital ratios were strong, and asset quality outperformed peers.Original document: TriCo Bancshares…
Q2 2026 saw 9% revenue growth, 10% higher adjusted DEPS, and 11% free cash flow growth, driven by strong segment performance and share repurchases. Full-year guidance was raised for both adjusted DEPS and revenue growth, with continued focus on acquisitions and AI innovation.Original document: Rope…
Second quarter results showed robust growth in credit sales, loans, and deposits, with revenue up 7% and net income up 5% year-over-year. Improved credit metrics and capital actions boosted tangible book value per share by 22%.Original document: Bread Financial Holdings, Inc. [BFH] SEC 8-K Current…
Q2 2026 delivered 9% revenue growth, 5% organic growth, and 11% higher free cash flow, prompting an increase in full-year guidance. AI initiatives advanced across segments, and significant capital was returned via share repurchases. Indicor's divestiture is expected to yield $1.4B.Original document…
GLMD (Galmed Pharmaceuticals Ltd.) is set to announce its Q2'26 results on July 30, time not specified. The earnings are expected to be disclosed at 8:00 AM ET (12:00 PM UTC).For Q2'26, EPS (earnings per share) is anticipated at (0.39) USD. Learn more details at GLMD Financials page.Revenue & EPS v…
UPLD (Upland Software, Inc.) is set to announce its Q2'26 results on July 30, time not specified. The earnings are expected to be disclosed at 8:00 AM ET (12:00 PM UTC).For Q2'26, revenue estimate is 48.61 million USD with EPS (earnings per share) anticipated at 1.59 USD. Learn more details at UPLD…
FBLG (FibroBiologics, Inc.) is set to announce its Q2'26 results on July 30, time not specified. The earnings are expected to be disclosed at 8:00 AM ET (12:00 PM UTC).For Q2'26, revenue estimate is 0 USD with EPS (earnings per share) anticipated at (0.93) USD. Learn more details at FBLG Financials…
CRIS (Curis, Inc.) is set to announce its Q2'26 results on July 30, time not specified. The earnings are expected to be disclosed at 8:00 AM ET (12:00 PM UTC).For Q2'26, revenue estimate is 1.00 million USD with EPS (earnings per share) anticipated at (6.98) USD. Learn more details at CRIS Financia…
NVNO (enVVeno Medical Corporation) is set to announce its Q2'26 results on July 30, time not specified. The earnings are expected to be disclosed at 8:00 AM ET (12:00 PM UTC).For Q2'26, revenue estimate is 0 USD with EPS (earnings per share) anticipated at (4.69) USD. Learn more details at NVNO Fin…
PASG (Passage Bio, Inc.) is set to announce its Q2'26 results on July 30, time not specified. The earnings are expected to be disclosed at 8:00 AM ET (12:00 PM UTC).For Q2'26, revenue estimate is 0 USD with EPS (earnings per share) anticipated at (2.65) USD. Learn more details at PASG Financials pa…
DAIO (Data I/O Corporation) is set to announce its Q2'26 results on July 30, after the market closes. The earnings are expected to be disclosed at 4:00 PM ET (8:00 PM UTC).For Q2'26, revenue estimate is 5.20 million USD with EPS (earnings per share) anticipated at (0.04) USD. Learn more details at…
BNGO (Bionano Genomics, Inc.) is set to announce its Q2'26 results on July 30, time not specified. The earnings are expected to be disclosed at 8:00 AM ET (12:00 PM UTC).For Q2'26, revenue estimate is 7.48 million USD with EPS (earnings per share) anticipated at (0.69) USD. Learn more details at BN…
NXTC (NextCure, Inc.) is set to announce its Q2'26 results on July 30, time not specified. The earnings are expected to be disclosed at 8:00 AM ET (12:00 PM UTC).For Q2'26, revenue estimate is 0 USD with EPS (earnings per share) anticipated at (1.95) USD. Learn more details at NXTC Financials page…
HBIO (Harvard Bioscience, Inc.) is set to announce its Q2'26 results on July 30, time not specified. The earnings are expected to be disclosed at 8:00 AM ET (12:00 PM UTC).For Q2'26, revenue estimate is 21.45 million USD with EPS (earnings per share) anticipated at (0.21) USD. Learn more details at…
ALGS (Aligos Therapeutics, Inc.) is set to announce its Q2'26 results on July 30, time not specified. The earnings are expected to be disclosed at 8:00 AM ET (12:00 PM UTC).For Q2'26, revenue estimate is 24.68 million USD with EPS (earnings per share) anticipated at (1.09) USD. Learn more details a…
UEIC (Universal Electronics Inc.) is set to announce its Q2'26 results on July 30, time not specified. The earnings are expected to be disclosed at 8:00 AM ET (12:00 PM UTC).For Q2'26, revenue estimate is 78.13 million USD with EPS (earnings per share) anticipated at 0.03 USD. Learn more details at…
SRTS (Sensus Healthcare, Inc.) is set to announce its Q2'26 results on July 30, time not specified. The earnings are expected to be disclosed at 8:00 AM ET (12:00 PM UTC).For Q2'26, revenue estimate is 4.60 million USD with EPS (earnings per share) anticipated at (0.12) USD. Learn more details at S…
OFS (OFS Capital Corporation) is set to announce its Q2'26 results on July 30, time not specified. The earnings are expected to be disclosed at 8:00 AM ET (12:00 PM UTC).For Q2'26, revenue estimate is 7.87 million USD with EPS (earnings per share) anticipated at 0.14 USD. Learn more details at OFS…
CPSH (CPS Technologies Corp.) is set to announce its Q2'26 results on July 30, time not specified. The earnings are expected to be disclosed at 8:00 AM ET (12:00 PM UTC).For Q2'26, revenue estimate is 8.24 million USD with EPS (earnings per share) anticipated at 0 USD. Learn more details at CPSH Fi…
MCHX (Marchex, Inc.) is set to announce its Q2'26 results on July 30, time not specified. The earnings are expected to be disclosed at 8:00 AM ET (12:00 PM UTC).For Q2'26, revenue estimate is 11.20 million USD with EPS (earnings per share) anticipated at 0.02 USD. Learn more details at MCHX Financi…
